GHRP-2 (5 mg) – Research Peptide for Growth Hormone Release
1. Peptide Overview
GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide that strongly stimulates pituitary GH secretion by mimicking ghrelin. It is widely studied for its potent anabolic and metabolic effects, making it valuable for muscle growth, fat loss, and recovery research.
2. Mechanism of Action
Binds to ghrelin receptors (GHS-R1a), triggering GH release.
Enhances hunger (due to ghrelin-like activity).
Increases IGF-1 levels, supporting muscle and tissue repair.
Mildly elevates cortisol & prolactin (less than GHRP-6).
3. Key Research Benefits
Muscle Growth: Promotes protein synthesis & nitrogen retention.
Fat Loss: Boosts lipolysis & metabolic rate.
Recovery Acceleration: Enhances collagen synthesis & injury repair.
Appetite Stimulation: Useful in studies on wasting conditions.
4. Administration Protocol
Dosage: 100–300 mcg, 2–3x daily (fasted state optimal).
Cycle Length: 6–12 weeks (followed by a break to prevent desensitization).
Injection Route: Subcutaneous or intramuscular.
5. Side Effects & Safety
Increased hunger (stronger than Ipamorelin).
Mild water retention (dose-dependent).
Possible short-term cortisol/prolactin rise (minimal at lower doses).
6. Best Stacking Combinations
CJC-1295 (DAC or no DAC): For sustained GH/IGF-1 elevation.
Ipamorelin: For cleaner GH pulses without hunger.
HGH Frag 176-191: For targeted fat metabolism.
7. Product Specifications
Purity: ≥98% (HPLC-tested).
Form: Lyophilized powder (5 mg/vial).
Storage: Store at 2–8°C (reconstituted solution stable for 7 days refrigerated).
Disclaimer: This product is intended for laboratory research purposes only. Not for human, veterinary, or diagnostic use.
